The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.2T>C (p.Met1Thr)

CA404071092

441174 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 7f40ca33-9ff0-4ff1-93fb-6c6a4b1bd789

HGVS expressions

NM_000527.5:c.2T>C
NM_000527.5(LDLR):c.2T>C (p.Met1Thr)
NC_000019.10:g.11089550T>C
CM000681.2:g.11089550T>C
NC_000019.9:g.11200226T>C
CM000681.1:g.11200226T>C
NC_000019.8:g.11061226T>C
NG_009060.1:g.5170T>C
ENST00000558518.6:c.2T>C
ENST00000455727.6:c.2T>C
ENST00000535915.5:c.2T>C
ENST00000545707.5:c.2T>C
ENST00000557933.5:c.2T>C
ENST00000557958.1:n.88T>C
ENST00000558013.5:c.2T>C
ENST00000558518.5:c.2T>C
ENST00000560502.5:n.88T>C
NM_000527.4:c.2T>C
NM_001195798.1:c.2T>C
NM_001195799.1:c.2T>C
NM_001195800.1:c.2T>C
NM_001195803.1:c.2T>C
NM_001195798.2:c.2T>C
NM_001195799.2:c.2T>C
NM_001195800.2:c.2T>C
NM_001195803.2:c.2T>C
NR_163945.1:n.110A>G

Likely Pathogenic

Met criteria codes 3
PM2 PM5 PVS1_Moderate
Not Met criteria codes 10
BS3 BS1 BP7 BP4 PS1 PS3 BA1 PP4 PP3 PM4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.2T>C (p.Met1Thr) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying evidence codes PM2, PVS1_Moderate, and PM5 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012) The supporting evidence is as follows: PM2 - variant is absent from gnomAD (v2.1.1). PVS1_Moderate – variant is predicted to affect the initiation codon. PM5 - four other missense variants at this same codon have been reported, and one is Pathogenic: 1) NM_000527.5(LDLR):c.1A>C (p.Met1Leu) – Pathogenic by these guidelines. 2) NM_000527.5(LDLR):c.1A>G (p.Met1Val) - Likely pathogenic by these guidelines. 3) NM_000527.4(LDLR):c.3G>A (p.Met1Ile) - Likely pathogenic by these guidelines. 4) NM_000527.5(LDLR):c.3G>T (p.Met1Ile) - Likely pathogenic by these guidelines.
Met criteria codes
PM2
Variant is absent from gnomAD (v2.1.1).
PM5
Four other missense variants at this same codon have been reported, and one is Pathogenic: 1) NM_000527.5(LDLR):c.1A>C (p.Met1Leu) – Pathogenic by these guidelines. 2) NM_000527.5(LDLR):c.1A>G (p.Met1Val) - Likely pathogenic by these guidelines. 3) NM_000527.4(LDLR):c.3G>A (p.Met1Ile) - Likely pathogenic by these guidelines. 4) NM_000527.5(LDLR):c.3G>T (p.Met1Ile) - Likely pathogenic by these guidelines.
PVS1_Moderate
Variant is predicted to affect the initiation codon.
Not Met criteria codes
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Approved on: 2022-04-22
Published on: 2022-04-22
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.